Clinical Trials Directory

Trials / Completed

CompletedNCT05625672

EFFICIENCY OF HEMOVIGILANCE MODULE TRAININGS GIVEN TO NURSES

EVALUATION OF THE EFFICIENCY OF HEMOVIGILANCE MODULE TRAININGS

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
125 (actual)
Sponsor
Ankara Yildirim Beyazıt University · Academic / Other
Sex
All
Age
18 Years – 64 Years
Healthy volunteers
Accepted

Summary

The aim of the present study is to determine the effectiveness of hemovigilance module training given to nurses.

Detailed description

125 nurses from the clinic and intensive care units, who received the most intensive blood transfusion from two different hospitals, were included in the study as the intervention and control groups. The control group was not trained. Only the pretest was administered one week after the posttest. After the pre-test was applied to the nurses in the intervention group, five modules of training, which lasted four hours, were given using interactive methods. Five modules of training were prepared by the researcher. These five modules are the 1st module of training; definition of hemovigilance, its aims, the development of hemovigilance in the world and in Turkey, and legal legislation, Module 2; Donor selection, Blood donation Process, Phlebotomy and Donor reactions, Module 3; blood, blood transfusion, its purpose, properties of blood and blood components, Blood transfusion process, Module 4; acute and delayed transfusion reactions and management, Module 5; It consists of the national hemovigilance system, the organization of the hemovigilance system at the hospital level, Traceability, Trace-back from the Patient to the Donor, and Look-back from the Donor to the Patient. the training was over, the final test was administered. One month later, this test was repeated.

Conditions

Interventions

TypeNameDescription
OTHERTrainingHemovigilance module training

Timeline

Start date
2022-04-25
Primary completion
2022-05-26
Completion
2022-07-08
First posted
2022-11-23
Last updated
2022-11-23

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05625672. Inclusion in this directory is not an endorsement.